Whitehawk Appoints Dr. Vijay Iyengar to Board of Directors
Whitehawk Therapeutics appointed Dr. Vijay Iyengar to its board, effective Sept. 9, bringing over 20 years of oncology and corporate strategy experience. This addition bolsters the company's leadership as it advances its ADC pipeline and aims to commercialize treatments.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
GET FREE KEY — 10,000 calls/day